title: [Relationship between cardioplegic dosage and effects of myocardial protection in patients with left ventricular hypertrophy].
authors.forename: S
authors.initials: S
authors.lastname: Maeda
authors.forename: H
authors.initials: H
authors.lastname: Hirose
authors.forename: H
authors.initials: H
authors.lastname: Matsuda
authors.forename: S
authors.initials: S
authors.lastname: Nakano
authors.forename: R
authors.initials: R
authors.lastname: Shirakura
authors.forename: T
authors.initials: T
authors.lastname: Sakakibara
authors.forename: M
authors.initials: M
authors.lastname: Kaneko
authors.forename: Y
authors.initials: Y
authors.lastname: Sasako
authors.forename: F
authors.initials: F
authors.lastname: Nonura
authors.forename: Y
authors.initials: Y
authors.lastname: Kawashima
mesh_terms: D000328:Adult; D001021:Aortic Valve; D006332:Cardiomegaly / Q000150:complications*; D003327:Coronary Disease / Q000517:prevention & control*; D006324:Heart Arrest, Induced / Q000379:methods*; D006349:Heart Valve Diseases / Q000150:complications / Q000601:surgery; D006350:Heart Valve Prosthesis; D006801:Humans; D008875:Middle Aged